Endo Axiom is focused on prevention of autoimmune diseases and improving the quality of life of diabetics. We develop biotechnology platforms for the oral delivery of drug and biologics and take these to clinical validation.
Headquarter Australia |
Countries of operation Australia |
Year founded 2023 (1 year) |
Funding status Private |
Company type SME |
Board Observer
Chief Executive Officer
Non Executive Director